IDEXX Laboratories Inc

0J8P.L | Healthcare | LSE
$717.65
-6.65 (-0.92%)

Key Metrics

Market Cap
$57.31B
P/E Ratio
84.26
EPS
$8.52
Beta
N/A
Dividend Yield
N/A
ROE
67.78%
Current Ratio
1.18

Company Information

Industry
Medical Equipment Services

About IDEXX Laboratories Inc

IDEXX Laboratories Inc develops manufactures and distributes products and services primarily for the companion animal veterinary livestock and poultry dairy and water testing markets worldwide The company operates through CAG Water Quality Products LPD and Other segments It provides pointofcare veterinary diagnostic products including instruments consumables and rapid assay test kits veterinary reference laboratory diagnostic and consulting services practice management and diagnostic imaging systems and services for veterinarians and health monitoring biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community The company also offers diagnostic and healthmonitoring products for livestock poultry and dairy products that test water for various microbiological contaminants and pointofcare electrolytes and blood gas analyzers and SARSCoV2 RTPCR that are used in the human pointofcare medical diagnostics market inclinic chemistry blood and urine chemistry hematology and SediVue Dx analyzers SNAP rapid assays test kits In addition it provides Colilert Colilert18 and Colisure tests which detect the presence of total coliforms and E coli in water Enterolert Pseudalert FiltaMax and FiltaMax xpress Legiolert and QuantiTray products veterinary software and services for independent veterinary clinics and corporate groups The company markets its products through marketing customer service sales and technical service groups as well as through independent distributors and other resellers IDEXX Laboratories Inc was incorporated in 1983 and is headquartered in Westbrook Maine

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-11-03 $3.40 $3.14 +8.3%
2025-08-04 $3.63 $3.30 +10.0%
2025-05-01 $2.96 $2.85 +3.9%
2025-02-03 $2.62 $2.40 +9.2%

Financial Ratios (TTM)

Gross Margin
61.72%
Operating Margin
31.34%
Net Margin
24.65%
ROA
30.34%
Price to Book
37.05
Price to Sales
13.86